Understanding the Impact of Antibiotics on Infant Gut Microbiota

Disruption of the gut microbiota in early life can lead to long-term health challenges. This peer-reviewed study investigates the use of a synbiotic mixture that combines prebiotics such as scGOS/lcFOS/2’-FL with a carefully selected mix of infant-type Bifidobacterium strains to support microbiota recovery following antibiotic treatment. Using an animal model reflecting early-life conditions like C-section, prematurity, or antibiotic exposure, the study shows how specific synbiotics help restore a more balanced gut microbiota and support intestinal and immune health.

Key Benefits for Healthcare Professionals

This resource offers valuable, practical insights to help you:

• Understand the impact of antibiotics like clindamycin on gut microbiota and intestinal function

• Evaluate how synbiotic supplementation supports microbiota diversity and resilience

• Learn how multi-strain Bifidobacterium formulations outperform single-strain or prebiotic-only approaches

• Identify improvements in gut barrier markers, inflammation levels, and mucosal recovery

• Translate research findings into nutritional strategies for infants at risk of microbiota disruption

Download the Full Publication

Click “View Content” or download the publication directly on our page to access the complete peer-reviewed article from a trusted scientific source. Inside the resource, you will find detailed data, expert interpretation, and clinical implications to support your practice.